NDC properties for NDC 9 43074-103
NDC item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
NDC item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
NDC item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
NDC item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
NDC item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
NDC item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |